Found 18 matching trials
Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) PHASE1 The study will evaluate the safety, tolerability, maximum administered dose...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714) PHASE3 This study is being conducted to demonstrate the superiority in progression...
Show More Location
Multiple Locations
Learn More & Join Trial
SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716) PHASE2 To determine the activity of SCH 727965 in participants with breast cancer ...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer PHASE1 The purpose of this trial is to determine the safety and tolerability (maxi...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155) PHASE1 The purpose of this study is to evaluate the safety and efficacy of pembrol...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia PHASE1 An open-label, dose-escalation study to assess safety, pharmacokinetics and...
Show More Location
University of Arkansas /ID# 200016
Learn More & Join Trial
Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia PHASE1 This phase I/II trial studies the side effects and the best dose of ofatumu...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715) PHASE2 Participants will be randomized to SCH 727965 or a comparator drug (bortezo...
Show More Location
Multiple Locations
Learn More & Join Trial
Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors PHASE1 This phase I trial studies the side effects and the best dose of veliparib ...
Show More Status
Active Not Recruiting
Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer PHASE1 This phase I clinical trial studies the side effects and the best dose of d...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial